Iterum Therapeutics plc Ordinary Share
Symbol: ITRM (NASDAQ)
0.74
▲ (5.14%) 0.036
Company Description:
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
Key Stats
- Today's Open: $0.7037
- Today's High: $0.737
- Today's Low: $0.693
- Today's Volume: 1.02M
- Yesterday Close: $0.701
- Yesterday High: $0.71
- Yesterday Low: $0.66
- Yesterday Volume: 658.10K
- Last Min Volume: 100
- Last Min High: $0.737
- Last Min Low: $0.737
- Last Min VWAP: $0.737
Company Profile
- Name: Iterum Therapeutics plc Ordinary Share
- Website: https://www.iterumtx.com
- Listed Date: 2018-05-25
- Location: DUBLIN 1, L2
- Market Status: Active
- CIK Number: 0001659323
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $29.49M
- Round Lot: 100
- Outstanding Shares: 44.66M
- Asset Type: CS
RECENT FILINGS FOR ITRM
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 8-K | View |
| 2025-08-28 | 8-K | View |
| 2025-08-20 | 8-K | View |
| 2025-08-12 | 4 | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-08-04 | 8-K | View |
| 2025-07-29 | DEF 14A | View |
| 2025-07-18 | 8-K | View |
| 2025-07-18 | PRE 14A | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 3 | View |
| 2025-06-11 | 8-K | View |
| 2025-05-19 | 8-K | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-04-30 | 8-K | View |
| 2025-04-30 | 424B5 | View |
| 2025-03-18 | 3 | View |
| 2025-03-10 | 8-K | View |
Latest News on ITRM